1,7-phenanthroline has been researched along with trientine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnham, KJ; Beyreuther, K; Bush, AI; Cherny, RA; Li, QX; Lynch, T; Masters, CL; McLean, CA; Multhaup, G; Tanzi, RE; Volitakis, I | 1 |
| Filipský, T; Hrdina, R; Karlíčková, J; Macáková, K; Mladěnka, P; Říha, M | 1 |
2 other study(ies) available for 1,7-phenanthroline and trientine
| Article | Year |
|---|---|
Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Chelating Agents; Copper; Humans; Mice; Mice, Transgenic; Nuclear Magnetic Resonance, Biomolecular; Penicillamine; Peptides; Phenanthrolines; Pilot Projects; Solubility; Trientine; Zinc | 2000 |
Novel method for rapid copper chelation assessment confirmed low affinity of D-penicillamine for copper in comparison with trientine and 8-hydroxyquinolines.
Topics: Copper; Oxyquinoline; Penicillamine; Phenanthrolines; Trientine | 2013 |